DMK Pharmaceuticals Corporation
DMK Pharmaceuticals Corporation (DMKPQ) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
dmkpq · pe ratio · data through Dec 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for DMK Pharmaceuticals Corporation (DMKPQ) measures how much investors pay for each dollar of the company's trailing earnings. DMKPQ's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$12.37.
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31
PE Ratio History
2016 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
DMK Pharmaceuticals CorporationYou DMKPQ | $0M | N/A | — | -$12.37 |
 American Medical Technologies Inc. ADLI | $0M | N/A | — | -$0.11 |
 HLK Biotech Holding Group, Inc. AMHD | $0M | N/A | — | — |
 BIMI International Medical Inc. BIMI | $0M | N/A | — | -$8.40 |
 ContraFect Corporation CFRXQ | $0M | N/A | — | -$124.97 |
 eFFECTOR Therapeutics, Inc. EFTR | $0M | N/A | — | -$16.37 |
 IMV Inc. IMVIF | $0M | N/A | — | -$4.37 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-12-31Latest FY2022 | — | $-12.37 | — | |
2021-12-31 FY2021 | — | $-22.25 | — | |
2020-12-31 FY2020 | — | $-44.57 | — | |
2019-12-31 FY2019 | — | $-36.16 | — | |
2018-12-31 FY2018 | — | $-69.86 | — | |
2017-12-31 FY2017 | — | $-63.06 | — | |
2016-12-31 FY2016 | — | $-77.75 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for DMK Pharmaceuticals Corporation (DMKPQ) measures how much investors pay for each dollar of the company's trailing earnings. DMKPQ's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$12.37.
Frequently asked questions
DMKPQ pe ratio · 6 questionsDMKPQ's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.00 and TTM EPS of -$12.37. Data sourced from Financial Modeling Prep via DMKPQ's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · DMK Pharmaceuticals Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08